Insider Trading activities of Pacific Biosciences Of California, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacific Biosciences Of California, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacific Biosciences Of California, Inc. since year 2005. Table 2 shows the detailed insider transactions of Pacific Biosciences Of California, Inc. since 2005. The reporting company's ticker symbol is PACB. The reporting company's CIK number is 1299130.
The total value of stock buying since 2005 is $5,920,090.
The total value of stock sales since 2005 is $1,438,392.
The total value of stock option exercises since 2005 is $3,086,466.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pacific Biosciences Of California, Inc. (PACB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 0 $0 256 $501
2017-07 0 $0 0 $0 28,061 $54,999
2017-06 0 $0 0 $0 860,421 $2,297,058
2016-10 0 $0 20,000 $168,720 20,000 $43,600
2016-07 0 $0 20,000 $168,920 20,000 $41,400
2016-04 0 $0 20,000 $205,720 20,000 $39,200
2016-01 0 $0 0 $0 101,666 $373,927
2015-08 0 $0 16,689 $77,003 31,663 $22,164
2015-03 7,196 $35,353 0 $0 0 $0
2014-08 405,134 $2,027,248 0 $0 0 $0
2013-12 100,000 $413,004 0 $0 0 $0
2013-11 200,000 $721,600 0 $0 0 $0
2012-12 56,700 $98,998 0 $0 0 $0
2012-11 943,300 $1,346,877 0 $0 0 $0
2012-08 400,000 $699,790 0 $0 0 $0
2012-02 0 $0 0 $0 69,174 $92,001
2011-08 100,000 $577,220 0 $0 65,000 $45,500
2011-07 0 $0 67,900 $818,029 0 $0
2011-05 0 $0 0 $0 38,835 $76,116

Table 2. Detailed insider stock purchases, sales, and option exercises of Pacific Biosciences Of California, Inc. insiders (PACB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-24 Corcoran Kevin P (SVP, Market Development) Option Ex 256 1.96 501
2017-07-20 Corcoran Kevin P (SVP, Market Development) Option Ex 28,061 1.96 54,999
2017-06-14 Corcoran Kevin P (SVP, Market Development) Option Ex 84,183 1.96 164,998
2017-06-02 Barnes Susan K (EVP, CFO and PAO) Option Ex 276,238 2.27 627,060
2017-06-01 Hunkapiller Michael (Chairman, CEO & President) Option Ex 500,000 3.01 1,505,000
2016-10-28 Phillips James Michael (SVP, Research & Development) Sale 20,000 8.44 168,720
2016-10-28 Phillips James Michael (SVP, Research & Development) Option Ex 20,000 2.18 43,600
2016-07-29 Phillips James Michael (SVP, Research & Development) Sale 20,000 8.45 168,920
2016-07-29 Phillips James Michael (SVP, Research & Development) Option Ex 20,000 2.07 41,400
2016-04-25 Phillips James Michael (SVP, Research & Development) Sale 20,000 10.29 205,720
2016-04-25 Phillips James Michael (SVP, Research & Development) Option Ex 20,000 1.96 39,200
2016-01-22 Shapiro Lucy (Director) Option Ex 101,666 3.68 373,927
2015-08-07 Phillips James Michael (SVP, Research & Development) Sale 16,689 4.61 77,003
2015-08-07 Phillips James Michael (SVP, Research & Development) Option Ex 31,663 .70 22,164
2015-03-02 Phillips James Michael (SVP, Research & Development) Buy 1,877 4.91 9,221
2015-03-02 Dow Brian B (VP and PAO) Buy 2,503 4.91 12,297
2015-03-02 Corcoran Kevin P (SVP, Market Development) Buy 2,816 4.91 13,835
2014-08-19 Ericson William W. (Director) Buy 39,299 5.14 201,996
2014-08-18 Ericson William W. (Director) Buy 135,155 5.09 687,533
2014-08-14 Ericson William W. (Director) Buy 77,822 5.00 388,720
2014-08-13 Ericson William W. (Director) Buy 29,435 4.92 144,967
2014-08-12 Ericson William W. (Director) Buy 123,423 4.89 604,032
2013-12-12 Hunkapiller Michael (Chairman, CEO & President) Buy 55,087 4.16 228,996
2013-12-11 Hunkapiller Michael (Chairman, CEO & President) Buy 44,913 4.10 184,008
2013-11-21 Hunkapiller Michael (Chairman, CEO & President) Buy 200,000 3.61 721,600
2012-12-03 Hunkapiller Michael (Chairman, CEO & President) Buy 56,700 1.75 98,998
2012-11-30 Hunkapiller Michael (Chairman, CEO & President) Buy 97,400 1.76 171,326
2012-11-29 Hunkapiller Michael (Chairman, CEO & President) Buy 97,400 1.74 169,183
2012-11-28 Hunkapiller Michael (Chairman, CEO & President) Buy 97,400 1.68 163,826
2012-11-27 Hunkapiller Michael (Chairman, CEO & President) Buy 47,400 1.55 73,659
2012-11-26 Hunkapiller Michael (Chairman, CEO & President) Buy 97,400 1.49 145,320
2012-11-23 Hunkapiller Michael (Chairman, CEO & President) Buy 50,000 1.45 72,350
2012-11-21 Hunkapiller Michael (Chairman, CEO & President) Buy 39,000 1.32 51,597
2012-11-20 Hunkapiller Michael (Chairman, CEO & President) Buy 65,600 1.27 83,246
2012-11-19 Hunkapiller Michael (Chairman, CEO & President) Buy 89,400 1.26 112,822
2012-11-16 Hunkapiller Michael (Chairman, CEO & President) Buy 100,000 1.21 121,200
2012-11-15 Hunkapiller Michael (Chairman, CEO & President) Buy 150,000 1.12 168,450
2012-11-14 Hunkapiller Michael (Chairman, CEO & President) Buy 12,300 1.13 13,898
2012-08-07 Hunkapiller Michael (Chairman, CEO & President) Buy 347,500 1.75 608,125
2012-08-06 Hunkapiller Michael (Chairman, CEO & President) Buy 52,500 1.75 91,665
2012-02-03 Martin Hugh C (Director) Option Ex 69,174 1.33 92,001
2011-08-10 Hunkapiller Michael (Director) Buy 30,000 5.68 170,310
2011-08-10 Siegel Susan E (Director) Option Ex 65,000 .70 45,500
2011-08-09 Hunkapiller Michael (Director) Buy 70,000 5.81 406,910
2011-07-06 Turner Stephen W (VP & Chief Technology Officer) Sale 30,000 12.07 362,070
2011-07-05 Turner Stephen W (VP & Chief Technology Officer) Sale 37,400 12.03 449,959
2011-07-01 Turner Stephen W (VP & Chief Technology Officer) Sale 500 12.00 6,000
2011-05-27 Martin Hugh C (Chairman, CEO & President) Option Ex 38,835 1.96 76,116

Insider trading activities including stock purchases, stock sales, and option exercises of PACB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacific Biosciences Of California, Inc. (symbol PACB, CIK number 1299130) see the Securities and Exchange Commission (SEC) website.